Phaarmasia Ltd.
Fundamentals
- Market cap
- ₹68.47 cr
- P/E
- 3.90×
- ROE
- 0.00%
- Debt / equity
- 0.00
- 52-week range
- 26.00 — 131.75
Company snapshot
Phaarmasia Ltd.
Pharmaceuticals
₹66 cr
P/E 3.73×
Latest quarter · Mar 2026
Sales₹8 cr
Net profit−₹1 cr
Op. margin−8.6%
EPS−₹1.03
Strength & growth
Debt / equity0.00×
Current ratio0.65×
Sales CAGR+13.2%
EPS CAGR+81.5%
The timeline — 3 notes on Phaarmasia Ltd.
May 2026
- 29 May 26 · 7:37 PM IST Brief Brief · Earnings · Micro cap
Phaarmasia's ₹17.57 cr profit is a one-off land sale
The nano-cap swung to profit on a ₹18.99 cr asset disposal, while operational revenue nearly doubled to ₹47.21 cr.
- 29 May 26 · 7:32 PM IST Brief Brief · Earnings · Micro cap
Phaarmasia's ₹18.99 cr land sale flips a ₹1.59 cr loss into a ₹17.57 cr profit
The pharmaceutical company's full-year profit is almost entirely a one-off from an asset sale. Operational revenue grew 94% to ₹47.21 crore, but the land gain is the story.
- 29 May 26 · 7:18 PM IST Brief Brief · Earnings · Micro cap
Phaarmasia approves FY26 results. The filing omits the numbers.
A procedural cover letter. The board signed off on annual results and named new auditors, but the actual financials are missing.